Nicole Alexander
Physician Assistant · Laramie, WYNPI 1831439108
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 51 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 21 manufacturers, the largest accounting for just 21.3% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $410 and has fallen 61.0% since, to $160 in 2025.
Across 51 payments — averaging $20.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$219
- Vanda Pharmaceuticals Inc.$101
- Lundbeck LLC$74
- Novo Nordisk$62
- Amgen$57
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$54
- plus $462 from 15 others
What the payments were for
- Food & beverage$1,028100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 10 | $219 |
| Vanda Pharmaceuticals Inc. | 3 | $101 |
| Lundbeck LLC | 3 | $74 |
| Novo Nordisk | 3 | $62 |
| Amgen | 4 | $57 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 3 | $54 |
| Merck | 3 | $54 |
| Medtronic | 2 | $54 |
| Abbott | 3 | $52 |
| Amarin Pharma, Inc. | 2 | $49 |
| Lilly USA, LLC | 3 | $42 |
| AstraZeneca | 2 | $37 |
| Axsome Therapeutics, Inc. | 1 | $35 |
| GSK | 2 | $34 |
| Alkermes, Inc. | 1 | $23 |
| Daiichi Sankyo Inc. | 1 | $16 |
| Esperion Therapeutics, Inc. | 1 | $15 |
| Exact Sciences | 1 | $15 |
| Astellas Pharma US Inc | 1 | $13 |
| E.r. Squibb & Sons, L.L.C. | 1 | $12 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $12 |
How this compares
$1,028 in reported general payments places this provider in the 75th percentile of 203 physician assistant providers in Wyoming.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 14 | $22,654 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 14 | $9,124 |
| Atorvastatin Calcium | 81 | $970 |
| Levothyroxine Sodium | 64 | $884 |
| Rosuvastatin Calcium | 29 | $737 |
| Metoprolol Succinate | 23 | $462 |
| Famotidine | 17 | $391 |
| Amlodipine Besylate | 31 | $361 |
| Omeprazole | 22 | $316 |
| Pantoprazole Sodium | 14 | $302 |
| Losartan Potassium | 17 | $299 |
| Gabapentin | 20 | $290 |
| Metformin Hcl | 25 | $277 |
| Pravastatin Sodium | 13 | $276 |
| Potassium Chloride | 12 | $274 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta | $34 | $9,12414 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 203 physician assistant providers in Wyoming.
Other physician assistant in Laramie
- Erena HintsaLaramie$928
- Hannah FourmanLaramie$734
- Tanja SloanSheridan$6K
- Joann RamseyCasper$5K
- Shawn RockeyRock Springs$4K
- Laurie JohnsonCasper$4K
- Robyn MorrisonCasper$4K
- Chloe LowneyAfton$4K
- Jennifer GraslieSheridan$4K
- Alison WatkinsCheyenne$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.